Faeth Therapeutics, Inc.
FTHAs of the close on Sep 25, 2026
Price
$28.00
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Faeth Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 26, 2026. The latest institutional report shown is dated Mar 31, 2025; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Ikarian Capital, LLC | 2025-03-31 | 449,963 | $177K | SEC filing |
| CITIGROUP INC | 2025-03-31 | 124 | $49 | SEC filing |
| Tower Research Capital LLC (TRC) | 2025-03-31 | 5,404 | $2.13K | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2025-03-31 | 142 | $56 | SEC filing |
| Cresset Asset Management, LLC | 2025-03-31 | 19,671 | $7.75K | SEC filing |
| NORTHERN TRUST CORP | 2025-03-31 | 25,983 | $10.2K | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2025-03-31 | 150,709 | $59.4K | SEC filing |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 2025-03-31 | 0 | $0 | SEC filing |
| STATE STREET CORP | 2025-03-31 | 25,774 | $10.2K | SEC filing |
| BOOTHBAY FUND MANAGEMENT, LLC | 2025-03-31 | 108,658 | $42.8K | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2025-03-31 | 177,300 | $69.9K | SEC filing |
| VANGUARD GROUP INC | 2025-03-31 | 585,576 | $231K | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2025-03-31 | 14,000 | $5.52K | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2025-03-31 | 160 | $63 | SEC filing |
| SBI Securities Co., Ltd. | 2025-03-31 | 92 | $36 | SEC filing |
| Catalio Capital Management, LP | 2025-03-31 | 294,374 | $116K | SEC filing |
| JPMORGAN CHASE & CO | 2025-03-31 | 702 | $276 | SEC filing |
| BARCLAYS PLC | 2025-03-31 | 2,558 | $1.01K | SEC filing |
| MORGAN STANLEY | 2025-03-31 | 9,219 | $3.63K | SEC filing |
| BARCLAYS PLC | 2025-03-31 | 2,558 | Not shown | SEC filing |
- Each value is checked against Faeth Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Faeth Therapeutics, Inc.'s share price.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- UBS Group AG: 2 shares reported 2024-12-31; 42,541 shares reported 2025-03-31.
- JPMORGAN CHASE & CO: 705 shares reported 2024-12-31; 702 shares reported 2025-03-31.
- Catalio Capital Management, LP: 294,374 shares reported 2024-12-31; 294,374 shares reported 2025-03-31.
- SBI Securities Co., Ltd.: 71 shares reported 2024-12-31; 92 shares reported 2025-03-31.
- BNP PARIBAS FINANCIAL MARKETS: 160 shares reported 2024-12-31; 160 shares reported 2025-03-31.
- VANGUARD GROUP INC: 594,454 shares reported 2024-12-31; 585,576 shares reported 2025-03-31.
- RENAISSANCE TECHNOLOGIES LLC: 156,800 shares reported 2024-12-31; 177,300 shares reported 2025-03-31.
- BOOTHBAY FUND MANAGEMENT, LLC: 172,798 shares reported 2024-12-31; 108,658 shares reported 2025-03-31.
- STATE STREET CORP: 25,774 shares reported 2024-12-31; 25,774 shares reported 2025-03-31.
- CONCOURSE FINANCIAL GROUP SECURITIES, INC.: 0 shares reported 2024-12-31; 0 shares reported 2025-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 148,887 shares reported 2024-12-31; 150,709 shares reported 2025-03-31.
- NORTHERN TRUST CORP: 25,983 shares reported 2024-12-31; 25,983 shares reported 2025-03-31.
Showing the 12 most recent filer reports.
10 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Faeth Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-01 · Cambrian BioPharma Inc: Larger than 43 of the 46 other insider sales of Common Stock on file. SEC filing
- 2026-06-01 · Peyer James: Larger than 43 of the 46 other insider sales of Common Stock on file. SEC filing
- 2023-06-01 · Apeiron Investment Group Ltd.: Larger than all 46 other insider sales of Common Stock on file. SEC filing
- 2023-06-01 · Apeiron Investment Group Ltd.: Larger than 45 of the 46 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2026-06-22–2026-06-26: 17 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2022-02-18–2022-02-25: 8 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing )
- 2022-02-17–2022-02-24: 8 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing )
- 2022-02-16–2022-02-23: 8 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing )
- 2022-02-11–2022-02-18: 10 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2022-02-10–2022-02-17: 10 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2022-02-08–2022-02-14: 8 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing )
- 2022-02-04–2022-02-11: 8 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing )
- 2022-02-03–2022-02-10: 8 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-26 | STEPHENSON BRIAN C · Chief Financial Officer | Common Stock | P — Open market or private purchase | +580 | 23.61 | SEC filing |
| 2026-06-26 | STEPHENSON BRIAN C · Chief Financial Officer | Common Stock | P — Open market or private purchase | +4,212 | 24.90 | SEC filing |
| 2026-06-26 | STEPHENSON BRIAN C · Chief Financial Officer | Common Stock | P — Open market or private purchase | +1,358 | 25.55 | SEC filing |
| 2026-06-26 | STEPHENSON BRIAN C · Chief Financial Officer | Common Stock | P — Open market or private purchase | +100 | 26.39 | SEC filing |
| 2026-06-24 | STEPHENSON BRIAN C · Chief Financial Officer | Common Stock | P — Open market or private purchase | +3,400 | 26.98 | SEC filing |
| 2026-06-24 | STEPHENSON BRIAN C · Chief Financial Officer | Common Stock | P — Open market or private purchase | +2,891 | 25.22 | SEC filing |
| 2026-06-24 | STEPHENSON BRIAN C · Chief Financial Officer | Common Stock | P — Open market or private purchase | +3,000 | 25.98 | SEC filing |
| 2026-06-24 | STEPHENSON BRIAN C · Chief Financial Officer | Common Stock | P — Open market or private purchase | +100 | 27.77 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-22 | Parikh Anand Kiran · President and CEO | Common Stock | M — Exercise or conversion of derivative security | +45,252 | SEC filing |
| 2026-06-22 | Parikh Anand Kiran · President and CEO | Employee Stock Option (right to buy) | M — Exercise or conversion of derivative security | −45,252 | SEC filing |
| 2026-06-22 | Parikh Anand Kiran · President and CEO | Common Stock | M — Exercise or conversion of derivative security | +8,213 | SEC filing |
| 2026-06-22 | Parikh Anand Kiran · President and CEO | Employee Stock Option (right to buy) | M — Exercise or conversion of derivative security | −8,213 | SEC filing |
| 2026-06-15 | Hahn Stephen M. · Director | Common Stock | C — Conversion of derivative security | +44,763 | SEC filing |
| 2026-06-15 | Hahn Stephen M. · Director | Series B Preferred Stock | C — Conversion of derivative security | −45 | SEC filing |
| 2026-06-15 | Parikh Anand Kiran · President and CEO | Series B Preferred Stock | C — Conversion of derivative security | −761 | SEC filing |
| 2026-06-15 | Parikh Anand Kiran · President and CEO | Common Stock | C — Conversion of derivative security | +761,428 | SEC filing |
Showing 8 of 29 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-07-31 | Peyer James · Director, 10% owner | Common Stock | D — Disposition to the issuer | −1,587,302 | SEC filing |
| 2023-07-31 | Cambrian BioPharma Inc · 10% owner, other | Common Stock | D — Disposition to the issuer | −1,587,302 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.